A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

Phase 1 Completed 12 enrolled Guangdong Hengrui Pharmaceutical Co., Ltd

RandomizedCrossoverOpen-labelTreatment

Summary

This is a phase Ⅰ study to evaluate the relative bioavailability of HRS-9813 capsule and tablet in healthy subjects and the effect of food on the pharmacokinetics of HRS-9813 capsule.

Timeline

Start: 2025-05-04
Primary completion: 2025-06-03
Completion: 2025-06-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-9813	Unknown	—	—

A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects

Summary

Timeline

Drugs

Indications